Your browser doesn't support javascript.
loading
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications.
Dong, Xin; Xue, Hui; Mo, Fan; Lin, Yen-Yi; Lin, Dong; Wong, Nelson K Y; Sun, Yingqiang; Wilkinson, Scott; Ku, Anson T; Hao, Jun; Ci, Xinpei; Wu, Rebecca; Haegert, Anne; Silver, Rebecca; Taplin, Mary-Ellen; Balk, Steven P; Alumkal, Joshi J; Sowalsky, Adam G; Gleave, Martin; Collins, Colin; Wang, Yuzhuo.
Affiliation
  • Dong X; Department of Experimental Therapeutics, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
  • Xue H; Vancouver Prostate Centre, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Mo F; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Lin YY; Department of Experimental Therapeutics, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
  • Lin D; Vancouver Prostate Centre, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Wong NKY; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Sun Y; Vancouver Prostate Centre, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Wilkinson S; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ku AT; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zheijiang, China.
  • Hao J; Hangzhou AI-Force Therapeutics, Hangzhou, Zhejiang, China.
  • Ci X; Vancouver Prostate Centre, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Wu R; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Haegert A; Department of Experimental Therapeutics, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
  • Silver R; Vancouver Prostate Centre, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Taplin ME; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Balk SP; Department of Experimental Therapeutics, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
  • Alumkal JJ; Hangzhou AI-Force Therapeutics, Hangzhou, Zhejiang, China.
  • Sowalsky AG; Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, Maryland.
  • Gleave M; Laboratory of Genitourinary Cancer Pathogenesis, National Cancer Institute, Bethesda, Maryland.
  • Collins C; Department of Experimental Therapeutics, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
  • Wang Y; Vancouver Prostate Centre, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Mol Cancer Res ; 20(5): 782-793, 2022 05 04.
Article in En | MEDLINE | ID: mdl-35082166
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant Limits: Animals / Humans / Male Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant Limits: Animals / Humans / Male Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Type: Article Affiliation country: Canada